BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ripley RT, Davis JL, Klapper JA, Mathur A, Kammula U, Royal RE, Yang JC, Sherry RM, Hughes MS, Libutti SK. Liver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapy. Ann Surg Oncol. 2010;17:163-170. [PMID: 19777192 DOI: 10.1245/s10434-009-0677-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 . Current world literature. Curr Opin Oncol 2011;23:227-34. [PMID: 21307677 DOI: 10.1097/CCO.0b013e328344b687] [Reference Citation Analysis]
2 Mallone F, Sacchetti M, Lambiase A, Moramarco A. Molecular Insights and Emerging Strategies for Treatment of Metastatic Uveal Melanoma. Cancers (Basel) 2020;12:E2761. [PMID: 32992823 DOI: 10.3390/cancers12102761] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Zippel DB, Besser M, Shapira R, Ben-Nun A, Goitein D, Davidson T, Treves AJ, Markel G, Schachter J, Papa MZ. Adoptive cell therapy with autologous tumor-infiltrating lymphocytes and high-dose interleukin-2 for metastatic melanoma: The surgeon's perspective. Exp Ther Med 2012;3:898-902. [PMID: 22969990 DOI: 10.3892/etm.2012.498] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
4 Wang WC, Zhang ZQ, Li PP, Ma JY, Chen L, Qian HH, Shi LH, Yin ZF, Sun B, Zhang XF. Anti-tumor activity and mechanism of oligoclonal hepatocellular carcinoma tumor-infiltrating lymphocytes in vivo and in vitro. Cancer Biol Ther. 2019;20:1187-1194. [PMID: 31018748 DOI: 10.1080/15384047.2019.1599663] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ringquist R, Ghoshal D, Jain R, Roy K. Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models. Adv Drug Deliv Rev 2021;179:114003. [PMID: 34653533 DOI: 10.1016/j.addr.2021.114003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Singh M, Durairaj P, Yeung J. Uveal Melanoma: A Review of the Literature. Oncol Ther 2018;6:87-104. [PMID: 32700136 DOI: 10.1007/s40487-018-0056-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
7 Du SD, Mao YL, Li SH, Sang XT, Lu X, Xu YY, Xu HF, Zhao L, Bai CM, Zhong SX, Huang JF. Surgical resection plus biotherapy/chemotherapy improves survival of hepatic metastatic melanoma. World J Hepatol 2012; 4(11): 305-310 [PMID: 23293716 DOI: 10.4254/wjh.v4.i11.305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Carvajal RD, Schwartz GK, Tezel T, Marr B, Francis JH, Nathan PD. Metastatic disease from uveal melanoma: treatment options and future prospects. Br J Ophthalmol. 2017;101:38-44. [PMID: 27574175 DOI: 10.1136/bjophthalmol-2016-309034] [Cited by in Crossref: 124] [Cited by in F6Publishing: 114] [Article Influence: 20.7] [Reference Citation Analysis]
9 Aubin J, Rekman J, Vandenbroucke-menu F, Lapointe R, Fairfull-smith RJ, Mimeault R, Balaa FK, Martel G. Systematic review and meta-analysis of liver resection for metastatic melanoma. British Journal of Surgery 2013;100:1138-47. [DOI: 10.1002/bjs.9189] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
10 Neri F, Ercolani G, Di Gioia P, Del Gaudio M, Pinna AD. Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature. Updates Surg 2015;67:223-33. [PMID: 26341625 DOI: 10.1007/s13304-015-0315-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
11 Li J, Liu H, Li L, Wu H, Wang C, Yan Z, Wang Y, Su C, Jin H, Zhou F, Wu M, Qian Q. The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma. Oncol Rep 2013;29:895-902. [PMID: 23292657 DOI: 10.3892/or.2012.2217] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
12 Ramia JM, García-Bracamonte B, de la Plaza R, Ortiz P, García-Parreño J, Vanaclocha F. [Surgical treatment of melanoma liver metastases]. Cir Esp 2013;91:4-8. [PMID: 23219418 DOI: 10.1016/j.ciresp.2012.10.002] [Reference Citation Analysis]
13 Alvarez-Downing MM, Inchauste SM, Dudley ME, White DE, Wunderlich JR, Rosenberg SA, Kammula US. Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma. World J Surg Oncol 2012;10:113. [PMID: 22726267 DOI: 10.1186/1477-7819-10-113] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
14 Agarwala SS, Eggermont AM, O’Day S, Zager JS. Metastatic melanoma to the liver: a contemporary and comprehensive review of surgical, systemic, and regional therapeutic options. Cancer. 2014;120:781-789. [PMID: 24301420 DOI: 10.1002/cncr.28480] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 6.4] [Reference Citation Analysis]
15 Höppener DJ, Grünhagen DJ, Eggermont AMM, van der Veldt AAM, Verhoef C. An Overview of Liver Directed Locoregional Therapies. Surg Oncol Clin N Am 2021;30:103-23. [PMID: 33220800 DOI: 10.1016/j.soc.2020.09.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Rozeman EA, Prevoo W, Meier MAJ, Sikorska K, Van TM, van de Wiel BA, van der Wal JE, Mallo HA, Grijpink-Ongering LG, Broeks A, Lalezari F, Reeves J, Warren S, van Thienen JV, van Tinteren H, Haanen JBAG, Kapiteijn E, Blank CU. Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM). Melanoma Res 2020;30:252-60. [PMID: 31895753 DOI: 10.1097/CMR.0000000000000653] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 15.0] [Reference Citation Analysis]